We show that a single injection of a recombinant, pathogenic antibody to MuSK, derived from a MuSK MG patient, triggers neuromuscular deficits in mice, which resemble neuromuscular disease in MuSK MG patients. Here, MUSK is linked to myasthenia gravis.